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It took a decade after the pioneering obser-
vations on prematurity made in 1936 [36] and 1967
[30], for us to realize that not all low birth weight
infants are premature. Certain infants are of low
birth weight for their gestational age regardless
of whether they are born prematurely, at term,
or even post term. We call these infants by a
variety of names [30, 17, 45, 46, 51], the most
common being intrauterine growth retarded
[52], small-for-dates [8], small for gestational
age [3] and intrauterine malnourished [43].
These names however, are simply descriptive
and in no way clarify the etiology of the growth
failure. The assumption has always been made
that the major cause of this syndrome was
"placental insufficiency" [17, 46, 3], However
the term "placental insufficiency" is itself vague,
never actually having been defined either mor-
phologically, physiologically or biochemically.
No doubt this terminology has been partly
responsible for our characterization of these
infants into a single syndrome. Recently we
have begun to realize that low birth weight
for gestational age does not define a single
syndrome. Just äs all babies under V2.500 gms
are not premature but constitute a heterogeneous
group, so all "small for dates" babies are not a
single entity; they too are a heterogeneous
group.
In this paper we would like to discuss some of
the current concepts related to fetal growth
retardation and to present new evidence sup-
porting the position that there are different types
of infants with intrauterine growth retardation
and that these different types can and should be
recognized.
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l Etiological classification of intrauterine
growth retardation
At present intrauterine growth retardation
(IUGR) is defined äs a birth weight below the
lOth percentile for a given gestational age [3].
This definition however, characterizes a variety
of different conditions. Although all of these
conditions ultimately affect fetal growth, some
may be "intrinsic" to the fetus or placenta
and pthers may be caused by "extrinsic"
factors acting directly on the fetus, both the
fetus and the placenta or the placenta prim-
arily and the fetus only secondarily. We
believe that the various entities comprising
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Fig. 1. Etiological chssiiicntion of intrautcrine growth retardation (IUGR).
IUGR can be classified within this broad cha-
racterixation. Fig. l presents our theoretical
modcl for the classification of IUGR.
1.1 Intrinsic causes of IUGR
1.1.1 Fetal
The "intrinsic" fetal causes of IUGR are due
to genctic factors, chromosomal abnormalities
or faulty difierentiation during organogenesis.
Evidence for genctic variations comes from
observntion of human populations and from
studies in experimental animals. In a study of all
babies born in Baltimore from 1959 through
1961 with an estimated gestational age of thirty-
six to thirty-seven weeks, approximately fifteen
per cent weighed 2000 gms or less [4]. This
weight is below the lOth percentile of the LUB-
cimNKO curve [29] for babies of this age and
consequently these infants could be considered
small-for-dates. Similar variations in body weight
have been described in newborn rhesus monkeys
bred in captivity [15]. Here the gestational age
can be carefully calculatcd and prematures not
inadvertently counted. It is impossible to
know the relative contributions of genetic
variability and environmental Stresses in
accounting for this wide ränge of birth
weights. However some of these cases can be
assumed to be genetically small rather than
growth retarded.
Chromosomal alterations of many diflerent va-
rietics result in IUGR. Trisomy 18 [37] and
TURNHK'S syndromc (45/XO) [39] are commonly
associated with a marked reduction in birth
weight. In addition many other congenital
anomalies without chromosomal alterations are
also associated with IUGR. This relationship of
multiple congenital anomalies and marked growth
failure is especially noticeable when the skeleton
or the central nervous System is involved [48].
1.1.2 Placental
A number of the "intrinsic" placental changes
which have been associated with IUGR have
been recently reviewed [44]. These include a
number of rare malformations of the placenta
such äs velamentous and battledore cord in-
sertions and vascular tumors of the placenta and
cord. In addition vascular transfusion in mono-
chorial twin placentas can be included in this
group.
1.2 Extrinsic causes of IUGR
1.2.1 Fetal
At this time, although they undoubtedly exist,
we are unable to identify with certainty any
external agents which aftect only the fetus and
not the placenta which are associated with IUGR,
although certain teratogenic agents may fall
into this category.
l .2.2 Feto-placental
A variety of external Stimuli will produce IUGR
by aftecting both the placenta and the fetus. Thus
the fetus fails to grow not only äs a consequence
of being directly affected by the agent but also
äs a consequence of placental involvement. A
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classic example of this type of IUGR is rubella
infection. Data collected during the 1963—1964
rubella epidemic in the U. S. demonstrated that
in a group of 58 infants with congenital rubella,
60 per cent were below the lOth percentile for
body weight [10]. Analysis of the placentas from
cases of congenital rubella, often demonstrate
villous placentitis and viral damage to the
vascular endothelium [12]. These findings are
consistent with the Interpretation that placental
blood circulation and subsequent function was
impaired.
Compared to rubella, Information is scarce
relating cytomegalovirus infection to IUGR.
However in a recent study seven out of twenty
infants with cytomegalovirus infection showed
marked growth retardation [31]. No correlation
was made between the cases of IUGR and any
placental pathology.
Low birth weight has also been associated with
other viral infections such äs herpes simplex,
and with parasitic infections such äs malaria and
toxoplasmosis. In a number of these infections
however it is difficult to distinguish from
available reports between prematurity and IUGR
[22].
Another environmental hazard, ionizing ra-
diation is known to cause severe growth re-
tardation associated with severe central nervous
System damage. However, whether or not the
placena ist also affected and hence classification
in this category is warranted is not well docu-
mented [63].
Perhaps the most common cause of IUGR in
this category is poor nutrition of the mother.
While we may still debate whether mild dietary
restriction will result in clinically recognizable
intrauterine growth retardation certainly severe
famines are associated with a high incidence of
low birth weight babies [5]. In addition, recent
studies in Guatemala have clearly demonstrated
an increase in about 400 gms in the birth weight
of infants from mothers with subclinical protein
calorie malnutrition when these women are
adequately supplemented with either calories or
protein [18]. Thus fetal growth is retarded in
underprivileged segments of developing coun-
tries and perhaps under these conditions the fetus
may become more "sensitive" to the effects of
other growth retarding Stimuli. It is possible
that the higher incidence of IUGR in low income
groups throughout the world [16] can be ex-
plained on this basis.
The mechanisms by which maternal mal-
nutrition retards fetal growth are poorly
understood. HAMMOND has theorized that, be-
cause of the higher metabolic rate of its tissues,
the fetus would be able to compete successfully
with the mother for available nutrients [19].
According to this theory fetal growth would be
retarded only after extreme maternal depletion.
HAMMOND, however, considered the placenta
merely äs a passive screen. Recent data have
demonstrated that maternal undernutrition in-
duces profound changes in placenta. DNA
content is reduced [54, 11] both the villous mass
and surface area are reduced [24] and the pro-
portion of free ribosomes to polysomes are
increased [25], All these changes demonstrate
that placenta like any other rapidly growing
organ is highly susceptible to the effects of
malnutrition [55]. The functional implications of
these placental changes are still unknown.
However at least one hormonal function, estriol
secretion, is retarded by maternal malnutrition
[23].
1.2.3 Placental
The placenta represents practically the only link
between the fetus and the mother. It is wholly
responsible for transporting nutrients to and
removing waste products from the fetus. In
addition, hormones secreted by the placenta are
responsible for some of the physiologic changes
of pregnancy which occur in the mother. By
inducing these changes the placenta may in-
directly influence its own growth and the growth
of the fetus. Thus any external Stimulus impeding
placental function may impede fetal growth in a
variety of ways.
The most common external factors affecting
the placenta all seem to retard utero-placental
blood flow. Just how this comes about and
the precise pathophysiology is still unknown.
However the fact that there is a higher incidence
of vascular lesions found in placentas from
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growth retarded infants strongly suggests some
type of "vascular insufficiency" mechanism
[17, 43]. Some of these lesions such äs pale
areas, large areas of ischemic necrosis of villi
and infarcts are also seen in placentas from nor-
mal newborns, indicating that the lesions are
nonspecific [43]. Thus it is the extent of the
damage and not the type of lesion which
determines whether fetal growth failure will
ensue. Other maternal conditions in which
vascular lesions of the placenta are likely to
develop are essential hypertension and collagen
vascular disease. More data from good clinical
studies are needed to characterize the extent and
type of the lesions in these conditions. Another
piece of evidence suggesting a vascular effect is
the clear relationship between toxemia and
IUGR [33].
1.2.4 Conditions not yet classifiable
Maternal smoking during pregnancy is strongly
associated with IUGR [41]. Several explanations
for this association have been offered. These
include carbon monoxide effects, reduced pla-
cental blood flow due to pharmacologic agents
and reduction in maternal food intake [27].
Thus smoking may act either by affecting the
placenta alone or by affecting the feto-placental
unit. Perhaps the most difficult type of IUGR to
classify is the s m all infant with a small pla-
centa. In infants falling within the normal ränge
of birth weights there is a direct correlation be-
tween fetal weight and placental weight [1].
Therefore it might appear logical that abnormally
small fetuses would have abnormally small
placentas. However this is not always true. In a
recent study only 26 placentas from a group of
50 babies with "placental insufficiency" and
intrauterine growth failure had a weight below
the lOth percentile [43]. Thus at least one half
of these children had a disproportionally
large placenta for their body weight. In ad-
dition there are isolated case reports supporting
this disproportional relationship. * For example,
there is the case of an infant born at 38 weeks
of gestation weighing 1885 g. The placenta was
scarred and showed extensive infarctions but
weighed 590g [17]. This inconsistency in the
relative placental to fetal weight in IUGR may
explain the inconsistency in the data which
compares fetal body weight/placental weight
ratios in normal infants with those in growth
retarded infants. Some studies describe an
elevated ratio [42, 62] whereas in other studies
the ratio was normal [64]. Attempts to further
characterize the small and large placentas from
IUGR have not been made.
From the data above, it should be apparent that
IUGR has multiple causes, some intrinsic to
the growing fetus or placenta and others im-
posed on them from the outside erivironment.
Recently we are also finding out, that clinically
all cases of IUGR do not look alike. Separation of
these infants into the proper clinical type often
allows us to classify them into the proper etio-
logic category and in addition may give us
valuable clues to both prognosis and therapy.
2 Clinical types of IUGR
Clinically, growth retarded neonates can be
separated into two large groups. Those with
obvious congenital malformations and those
without. The Separation into the proper group
is quite simple and depends entirely on a careful
physical examination. These two major groups
can be further subdivided into a clinical classi-
fication äs seen in Fig. 2.
2.1 Infants with multiple congenital
anomalies
The etiology of the growth failure äs well äs of
the malformations may be either "intrinsic" or
"extrinsic" to the fetus and placenta. In all of
these infants the growth failure is a secondary
Symptom. The type of growth failure seen is
variable. The relative growth of the head to the
rest of the body differs with different types of
anomalies. For example, babies with. DOWN'S
syndrome have a reduced head circumference/
body length ratio [28]. The infants with multiple
birth defects can be recognized at birth by the
type of malformation or by the signs and Symp-
toms of the disease entity causing the malfor-
mations. In the infants with "intrinsic" growth
failure the problem seems to involve only the
fetus, the placenta appearing normal. A study
J. Perinat. Med. 2 (1974)
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Fig. 2. Clinical classification o£ intrauterine growth retardation (IUGR).
examining placenta in these cases has revealed
that placental weight, cell number (DNA con-
tent) and protein and RNA per cell were all
normal [56]. By contrast in infants whose growth
failure is caused by extrinsic factors, generally
intrauterine infections, considerable placental
pathology can be found. For example, äs pre-
viously mentioned in cases of congenital rubella
villous changes and changes in the vascular
endothelium are prominent [12].
2.2 Infants without congenital anomalies
It is these infants again referred toin, the literature
äs "intrauterine malnourished" [30, 34,42], who
constitute the major problem to the clinician äs
far äs diagnosis, prognosis and therapy is con-
cerned. Except f or those falling into the genetically
small group all of these infants are growth
retarded by virtue of external forces working on
either the placenta or the f etoplacentaL unit. The
genetically small infants can be diagnosed by
exclusion, by their normal proportions and by
the size of their parents and other close relatives
[49]. They always fall between the lOth and
3rd percentile of weight for gestational age.
In the great majority of the infants in this cat-
egory external "stresses" have resulted in retar-
dation of normal growth. Clinically these in-
fants can be divided into two types depending
on the relative growth of the head and body
length to the rest of the organs of the body
[7], Type I is a small infant with a proportionally
small head and reduced body length and body
weight. Type II is a small infant whose head
and length is relatively normal size for the
gestational age and whose weight/length ratio
is reduced [47]. Although these two types are
relatively easy· to-.distinguisfe wheir they occur
in the pure form it is conceivable that a con-
siderable amount of overlap may be present. We
will examine the evidence demonstrating the
existence of these two clinical types and some of
their most likely etiologies and then attempt to
classify a number of infants who may fall into
either category.
2.2.1 Typel IUGR
Clinically these infants appear small, normally
proportioned and remind one of the infant
who is suffering from a mild postnatal caloric
deprivation [9] (Fig. 3). This type of growth
failure has been produced in experimental
animals by restricting the protein or calorie
intake of the mother [57]. Under these con-
J. Perinat. Med. 2 (1974)
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Fig. 3. Infant born at 36 weeks of gestation weighing
860g showing clincal characteristics of IUGR Type I.
ditions biochemical ar.d cellular changes are in-
duced in both the placenta and fetal organs
early in gestation. For example reduction in the
activity of DNA polymerase, a change cha-
racteristic of postnatal malnutritioh, is present in
placentas from malnourished dams [6]. In ad-
dition cell division is retarded in placental and
fetal organs. Fetal brain shows about a 15 to
20% reduction in cell number. Other organs
of the fetus show retarded cell division to ap-
proximately the same degree äs brain so that
liver and other organs also have 15—20% fewer
cells [57], Thus we have proportional growth
failure; all organs retarded to approximately
the same extent. If the malnutrition is continued
postnatally for the first twenty one days of the
(thus malnutrition has been present throughout
the entire period when brain cells are dividing),
there is a 60% reduction in brain cell number by
the time the animal is weaned [60]. It would
appear that undernutrition imposed throughout
gestation and lactation has an effect which is
more than additive.
Does the human counterpart of this Situation
exist? More and more evidence is suggesting
that it does. A recent report in which 1.044
consecutive autopsies of well preserved stillborn
and newborn infants in New 'York City were
analyzed indicates a clear correlation between
fetal growth and maternal nutrition [35],
This study demonstrates that mothers who were
underweight before pregnancy and had a very
low gestational weight gain, and whose dietary
intake of protein and calories was poor, delivered
small babies. The subsequent analysis of the fetal
organs demonstrated a 13 per cent reduction of
brain weight and a similar reduction for other
organs including placenta: a picture aiialogous to
the effects of maternal dietary restriction in the
rat (Tab. I).
Tab. I. Effect of maternal malnutrition on fetal growth
and the growth of several organs in rats and humans at
21 and over 33 weeks of gestation respectively; values are



























* data from original unpublished observations
As with the animal model, there is the Suggestion
that infants suffering combined prenatal and
postnatal malnutrition, will result in a more
than additive effect on the reduction of brain
cell number. Infants who die of marasmus but
who were of normal birth weight have a reduction
of brain cell number around 15—20%. By con-
trast, infants who die of marasmus but who
weighed less than 2000 gms at birth show a
60% reduction in cell number [61]. These data
suggest that these infants were either prernature
and the premature is more susceptible to the
effects of postnatal malnutrition or that these
J. Pcrinat. Med. 2 (1974)
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infants failed to grow in utero bccause of matcrnal
malnutrition and that this represents the clinical
counterpart o£ the doubly deprived rat discussed
above.
The mechanisms by which maternal under-
nutrition either experimentally induced or
naturally occurring causes this type of fetal
growth failure are poorly understood. How-
cver, studies presently underway would suggest
that the transport by the placenta of certain
nutrients might be impeded [40],
From a practical standpoint, the newborn with
Type I IUGR usually is the product of an under-
nourished mother, although probably other
environmental Stresses will be found which
produce this type of IUGR.
2.2.2 Type II IUGR
When the clinician is faced with a neonate born
either at or before term who is of low birth
weight for gestational age but whose head
circumference and body length are near or at
normal for gestational age he is most likely
dealing with the product of a vascularly
deprived uterine environment (Fig. 4). Again
the data have been generated from animal models
and human observations. The animal model
most studied is the pregnant rat in which the
uterine artery supplying one hörn of the bicor-
nate uterus has been ligated. This results in a
reduction in blood flow to that hörn which is now
entirely supplied by the ovarian arteries [53].
Comparisons can then be made between fetuses
in the ligated (compromised) and non-ligated
(control) hörn. When the ligation is performed
on the 17th day of gestation certain changes are
induced in both placenta and fetal organs.
Placental RNase activity increases dramatically
shortly after the ligation [50]. Fetal growth is
retarded, but this retardation is disproportional.
Brain weight, DNA, RNA and protein content
are all normal. By contrast fetal liver shows a
40—50% reduction in weight, DNA, RNA and
protein content [57]. In addition the liver is
totally depleted in glycogen content [21]. Thus
we have not only disproportionate growth
failure but this small depleted liver has to supply
glucose to a relatively large brain.
Fig. 4. Infant born at 36 weeks of gestation weighing
960g showing clinical charactcristics of IUGR Type II.
Tab. II. Effect of uterine artery ligation at day 17 in the
rat and "placental insufficiency" in human fetuses at term
on fetal growth and the growth of several organs; values



























* data from original unpublished observations
** Reduced brain weight suggests that not all the cases
,were typical IUGR Type II
Again whether or not a human counterpart o£
this model exists is not fully documented but
certain observations suggest that it does. For
example, it has been reported that infants with
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IUGR have hematologic changes secondary to
hypoxemia [13, 14] indirectly suggesting that
vascular insufficiency may be an important
factor in the etiology of some cases of IUGR
(Type II). It is conceivable that in these cases
hypoxemia would have a synergistic growth
retarding effect together with lack of nutrients.
There is direct evidence in human population
that hypoxia will retard fetal growth [2, 26]. The
IUGR found in affluent populations is more
likely to be of this type (Tab. II).
Another type of infant falling into the type II
category is the postmature infant. Again we have
a long thin baby with a relatively normal head
circumference. This type of infant can be dif-
ferentiated if a careful gestational history is
obtained.
2.2.3 Mechanisms of intrauterine growth
retardation Type I and Type Π
The mechanisms by which these two types of
growth retardation are determined are yet
unknown. Clearly there are two factors involved
in the animal studies: the timing of the ex-
periments and the type of Stimulus that is
used. Although the time at which the effects of
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Fig. 5. Intrauterine growth of infants suffering IUGR Type I. Each point represents a separate infant whose
measurements were obtained at birth [47].
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placenta and the fetus is still unknown these
effects probably Start before day 17 of pregnancy.
This assumption is based on the fact that placental
DNA, which normally increases until day 17,
is decreased in the malnourished rats [57]. The
rate of growth of the fetal organs is different
before and after day 17 [58] and consequently the
effects of malnutrition, or any other factor that
interferes with growth of the tissues, would also
be different. This would explain why the brain,
which near term is growing more slowly than
liver, is spared when the uterine artery is ligated,
whereas liver DNA is markedly reduced. How-
ever, what is perhaps a more plausible explanation
of the disproportionate growth failure is that the
fetus near term acquires the capacity to
readjust blood circulation to the different or-
gans during periods of stress [38]. It is likely
that such mechanisms are triggered by the
sudden hypoxemia induced by vascular in-
sufficiency. Several types of evidence support this
possibility [32], including experiments done in
Rhesus monkeys in which vascular insufficiency,
produced by ligation of the bridging vessels of
the usual bidiscoid placentas, caused a marked
body growth retardation without affecting the
brain [20].
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Fig. 6. Intrauterine growth of infaats suffering IUGR Type II. Each point represcnts a separate infant whose
measurements were obtained at birth [47].
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proportions in the two types of human IUGR,
without congenital malformations, found in
human populations were also due to factors
operating at different times during gestation [47];
before 28—30 weeks of gestation for Type I and
34—36 weeks of gestation for Type II (Figs. 5
and 6). However these speculations were made
without any data correlating clinical types with
placeiital growth. Since the amount of placental
DNA increases in the human until 34—36 weeks
[59], the placenta from Type I infants should
have a marked reduction in DNA content. By
contrast, placentas from Type II infants should
have a normal or slightly reduced DNA content.
There are data indicating that in infants with
lUGR approximately 50 percent of the placental
weight is above the lOth percentile [43]. This
fact strongly suggests that like the infants, the
placentas may also be divided into two
groups.
It is imperative in future studies to test this
possibility. It is equally important for our better
understanding of the mechanisms which deter-
mine IUGR to correlate placental growth and
placental histological and biochemical charac-
teristics.
Histologically placentas from IUGR babies can
be divided into two groups: those with multiple
lesions and those without [24]. It would be
interesting to know whether the incidence of
histologic lesions differs in small and large pla-
centas. The ans wer may provide new insight into
the mechanisms determining the two types of
IUGR.
3. Comment
This clinical classification although useful is
by no means infallable. Their is a considerable
overlap both in the clinical picture and also in the
etiology of the types of IUGR, but this classi-
fication at least is an ättempt to bring some
order into the diagnosis of IUGR so that sub-
sequent studies will be able to define exactly
what type of infant they are talking about.
Infants who fail to grow in utero can be classified
clinically into a number of different categories and
types within those categories. Once this is done a
rational approach to determining the etiology of
the growth failure can be made. Now doubt, äs
more etiologies are uncovered and äs riiore clinical
types are recognized these classifications will
need to be expanded, modified or even discarded
but for the present we suggest them äs an aid to
obstetriciäns and pediatricians faced with the
problem of a growth retarded infant. In addition,
we suggest that researchers in describing the
biochemical or physiologic changes in IUGR or
the clinical characteristics and prognosis of these
babies should classify them into the proper
categories so that a better understanding of the
particular type of infant being described is
possible.
Keywords: Fetus, growth (cellular), growth disorders, newborn, placenta.
Zusammenfassung
Die intrauterine Wachstums-Retardierung
Ein neuer systematischer Vorstoß, der auf den kli-
nischen und biochemischen Charakteristika dieses
Zustandes aufbaut
Die in jüngster Zeit gewonnenen Erkenntnisse lassen ver-
muten, daß Üntergewichtigkeit relativ zum Gestations-
alter kein einheitliches Syndrom darstellt. In der vor-
liegenden Arbeit werden einige gängige Vorstellungen
über die fetale Wachstums-Retardierung besprochen und
neue Daten vorgelegt, die die Auffassung unterstützen,
daß es zwei verschiedene, voneinander abgrenzbare Arten
von intrauteriner Wachstums-Retardierung (IUGR) gibt.
Die Ursachen für eine IUGR (Fig. 1) im Hinblick auf den
Feten und die Plazenta können aufgeteilt werden in
endogen ("intrinsic") und exogen ("extrinsic"). In der
Gruppe der endogenen fetalen Ursachen sind die ge-
netischen Faktoren, Chromosomenanomalieri * oder eine
fehlerhafte Entwicklung während der Organogenese die
häufigsten. Endogene plazentare Ursachen sind selten;
zu ihnen gehören Plazenta-Tumoren, abnormale Nabel-
schnur-Irisertionen und Zwillingsschwangerschaften mit
Parabiose.
Die exogenen fetalen Ursachen einer IUGR wurden
bisher nicht klar herausgearbeitet, wenngleich gewisse
tetratogene Substanzen in diese Ursachen-Gruppe hinein
gehören. Im Gegenteil, eine Vielzahl von Fällen mit
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IUGR sind durch exogene Faktoren bedingt, welche Fet
und Plazenta als Einheit gleichermaßen berühren. In
solchen Fällen kann der Fet nicht nur als Folge der
direkten Beeinflussung durch die Substanz, sondern
ebenso aufgrund der Plazenta-Beteiligung nicht
regelrecht wachsen. Die Röteln-Infektion ist ein Bei-
spiel für eine solche IUGR. Die Untersuchung der Pla-
zenten von Fällen mit kongenitaler Rubella-Infektion
zeigt häufig eine villöse Plazentitis und virusbedingte
Schäden der Gefäß-Endothelien. Der Herpes simplex, die
Syphilis, die Malaria und die Toxoplasmose sind andere
infektiöse bzw. parasitäre Erkrankungen, die mit einer
IUGR einhergehen.
Es ist in einer Anzahl von Fällen mit diesen Infektions-
Krankheiten schwierig, aus den verfügbaren Unterlagen
zu entscheiden, ob es sich um eine Prämaturität oder um
eine IUGR handelt.
Man weiß, daß ionisierende Strahlen eine IUGR verur-
sachen können, wobei die IUGR mit einer schweren Schä-
digung des ZNS verbunden ist. Ob jedoch in diesen Fällen
auch die Plazenta betroffen ist und demzufolge eine Zutei-
lung zu dieser Kategorie wünschenswert erscheinen läßt,
geht aus den Unterlagen nicht einwandfrei hervor.
Mangelernährung der Mutter ist vermutlich eine der
häufigsten Ursachen für die exogene, fetoplazentare
IUGR. Über Untersuchungen bei Hungernden hinaus
haben Studien in Guatemala kürzlich gezeigt, daß die zu-
sätzliche Gabe von entweder Kalorien oder Proteinen an
mutmaßlich unterernährte Mütter zu einer Zunahme des
Geburtsgewichtes von ungefähr 400 g führt.
Der häufigste exogene Faktor, der vor allem die Plazenta
beeinträchtigt, scheint die Drosselung der utero-pla-
zentaren Durchblutung zu sein. Diese vaskuläre In-
suffizienz findet ihren Niederschlag im häufigeren Vor-
kommen von Gefäß-Läsionen in Plazenten von Kindern
mit Wachstums-Retardierung. Einige dieser Läsionen, wie
z. B. blasse Bezirke, große Areale mit ischämischer Ne-
krose der Zotten und Infarkte findet man auch in Plazenten
von normalen Neugeborenen, was darauf hinweist, daß
diese Veränderungen nicht spezifisch sind.
Einige Zustandsbilder mit IUGR, die bei starken Rau-
cherinnen oder bei kleinen Plazenten auftreten, sind bis-
hier nicht klassifizierbar.
Aus klinischer Sicht können die in ihrem Wachstum
zurückgebliebenen Neugeborenen in zwei Hauptgruppen
eingeteilt werden (Fig. 2):
Jene mit klar erkennbaren und jene ohne angeborene
Mißbildungen. Kinder mit multiplen Geburtsfehlern
können normale Plazenten haben, wie dies bei Neuge-
borenen mit chromosomalen oder plazentaren Abnormali-
täten der Fall ist. Im letztgenannten Fall ist in der Regel
eine schwere Entzündung, wie z. B. bei einer angeborenen
Röteln-Infektion in der Früh-Gravidität die Ursache.
Die Gruppe ohne angeborene Mißbildungen wird von
drei Typen von Kindern gebildet. Der eine Typ ist der
genetisch bedingte Kleinwuchs, den man folglich nicht
als Wachstums-Retardierung auffassen kann. Die anderen
beiden Typen, die gemeinhin als „intrauterin-mangel-
ernährt" angesprochen werden, können in einen Typ I
und II aufgeteilt werden. Typ I bezeichnet ein kleines
Kind mit proportioniert kleinem Kopf, reduzierter Kör-
perlänge und verringertem Gewicht (Fig. 3, Tab. I).
Typ II ist ein kleines Kind, dessen Kopf und Körper-
länge relativ zum Gestationsalter vergleichsweise normale
Masse auf weisen und dessen Quotient aus Körperlänge
und Gewicht vermindert ist (Fig. 4, Tab. II). Beide
Arten von IUGR konnten im Experiment entweder durch
Einschränkung der Protein- oder der Kalorien-Zufuhr an
die Mutter bzw. durch Verringerung der plazentaren
Durchblutungs-Größen nachgeahmt werden. Die Ätiologie
dieser beiden Arten von IUGR beim Menschen ist unbe-
kannt, wenngleich die verfügbaren Daten vermuten
lassen, daß die mütterliche Mangel-Ernährung für
Typ I und Gefäß-Faktoren für Typ II verantwortlich
sind. Obwohl die Befunde bei einer großen Anzahl von
Fällen eine bestimmte Art von Wachstums-Retardierung
für verschiedene Organe erkennen lassen, die mit jener im
experimentellen Modell identisch ist, sind die Beweise,
welche diese Schlußfolgerung stützen, indirekter Natur.
Es wird gefordert, daß zwei Faktoren bei der Ausbildung
dieser beiden Arten von IUGR beteiligt sein können:
Der Zeit-Faktor und das Vermögen des Feten, sich auf
hypoxämische Situationen einzustellen. Die letztge-
nannte Möglichkeit mag erklären, warum das Gehirn bei
der Gefäß-Insuffizienz oder dem Typ II nicht betroffen
ist.
Obwohl diese klinische Einteilung nützlich erscheint, ist
sie keinesgewgs unanfechtbar; mit ihr wurde versucht, in
das Zustandsbild der IUGR etwas Ordnung zu bringen
mit dem Ziel, für künftige Studien eine exakte Definition des
Typus der zu untersuchenden kindlichen IUGR 2u er-
möglichen.
Schlüsselwörter: Fet, Neugeborenes, Plazenta, Wachstum (zelluläres), Wachstumsstörungen.
Resume
Retardement somatique intra-uterin. Une nouvelle
approche systematique basee sur les caracteristiques
cliniques et biochimiques de cette condition
Les dernieres observations donnent a penser que Pinsuf-
fisance de poids du foetus par rapport ä Tage de ge-
station ne definit pas un seul syndrome. Ce present
article expose diverses hypotheses relatives au retardement
somatique foetal ainsi que les observations recentes sur
l'existence probable de types reconnaissables differents
de sujets au retardement somatique intra-uterin. (IUGR:
Intrauterine growth retardation).
On peut diviser les causes de PIUGR (Fig. 1) en causes
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"intrinseques" et "extrinseques" au foetus et placenta.
Parmi les premieres, les plus frequentes sont les facteurs
genetiques, les anormalites chromosomiques ou une
differenciation fautive durant Porganogenese. Les causes
"intrinseques" placentaires sont rares et elles supposent
certaines conditions telles que les tumeurs placentaires,
Pinsertion anormale du cordon ombilical et la gestation
gemellaire parabiotique.
Les causes foetales "extrinseques" de PIUGR n'ont pas
encore ete indentifiees, bien qu'on puisse sans doute classer
dans cette categorie certains agents teratogeniques. A
Poppose, une serie de cas d'IUGR sont causes par des
facteurs "extrinseques" affectant simultanement Punite
foeto-placentaire. Ici, le foetus ne grandit pas non
seulement parce qu'il est atteint directement par
Pagent, mais aussi par suite de ratteinte placentaire.
Un exemple de ce type d'IUGR est Pinfection rubeöleuse.
L'examen de placentas de cas de rubeole congenitale
revele souvent, en effet, une placentite villeuse et une
lesion virale de rendothelium vasculaire. Les autres
maladies infectieuses ou parasitaires associees a PIUGR
sont le Herpes simplex, la Syphilis, la malaria, la toxo-
plasmose. II est toutefois difficile pour un certain nombre
de ces infections de dechiffrer dans les rapports serieux
s'il s'agit de prematurite ou de retardement somatique
intra-uterin.
La radiadon ionisante est connue pour provoquer une
IUGR associee a de graves lesions du Systeme nerveux
central. Quoi qu'il en soit, le placenta est aussi atteint, ce
qui assure la classification dans cette categorie meme avec
une documentation insuffisante.
La rnalnutrition tnaternelle est probablement l'une des
causes les plus repandues de FIUGR foetoplacentaire
"extrinseque". En plus des rapports relatant les famines,
des etudes recentes effectuees au Guatemala ont illustre
une augmentation de 400 g environ du poids du nouveau-
ne de meres presumees sous-alimentees et qui avaient
re£u des Supplements de calories ou de proteines.
Les facteurs externes les plus repandus afFectant en premier
Heu le placenta semblent etre une reduction du flux de
sang ut^roplacentaire. Cette insuffisance vasculaire se
reriete dans une incidence plus elevee de lesions vasculaires
trouvees dans les placentas de sujets avec retardement
somatique intra-uterin. Certaines de ces lesions, telles que
les aires päles, les aires larges de necrose ischemique de
villi et «les infarctus, etant aussi observees dans les placentas
de nouveaux-nes normaux, elles ne peuvent donc pas
etre considerees comme specifiques.
Certaines conditions, comme PIUGR, associees ä Pusage
de tabac chez les meres ou a des petits placentas ne peuvent
pas encore etre classees.
Cliniquement, les nouveaux-nes avec retardement so-
matique intra-uterin peuvent etre divises en deux groupes
principaux (Fig. 2): Tun avec malformations congeni-
tales manifestes et l'autre sans. Les enfants souffrant de
multiples defections natales peuvent avoir des placentas
normaux, comme les bebes ayant des anormalites chromo-
somiques, ou des placentas anormaux. Dans le dernier cas,
il s'agit souvent d'infections graves telles que la rubeole
congenitale en debut de grossesse.
Le groupe sans malformations congenitales comporte
trois types d'enfants, dont l'un est le groupe des enfants
genetiquement petits, qui ne peuvent donc pas etre
consideres comme somatiquement retardes. Les deux
autres types, designes communement sous la rubrique de
"maltrunition intrauterine", peuvent £tre divises en
Type I et Type II. Le Type I est un enfant petit, dont la
tete est proportionellement petite et dont la taille et le
poids sontreduits (Fig. 3, Tab.I). Le Type est un enfant
petit, dont la tete et la taille sont relativement normales
pour Page de gestation, mais dont le rapport poids/taille
est reduit (Fig. 4, Tab. II).
Les deux types d'IUGR ont ete le resultat d'exemples
experimentaux ä la suite soit d'une restriction des proteines
ou des calories chez la mere, soit d'une diminution du
volume sanguin penetrant le placenta. On ignore Petio-
logie de ces deux types d'IUGR chez Phomme, bien qu'on
soit en droit de supposer que le Type I est la conse-
quence d'une rnalnutrition maternelle et que, comme
chez le rat, il soit possible d'associer des facteurs
vasculaires au Type . L'evidence appuyant cette con-
clusion est, neanmoins, "indirecte", bien que les donnees
obtenues ä partir d'un grand nombre de cas montrent un
eventail de retardement somatique pour les divers organes
qui est identique au modele experimental.
En postulat apparait la possibilite de "faire entrer les deux
facteurs suivants dans la determination de ces deux types
d'IUGR: Le"timing" et la capacite du foetus de s'adap-
ter a Phypoxemie. La derniere possibilite expliquerait
pourquoi le cerveau reste epargne dans Pinsuffisance
vasculaire ou Type II.
Cette classification clinique, bien qu'utile, n'est en aucun
cas infaillible et est presentee comme une tentative pour
clarifier le diagnostic de PIUGR afin que Jes etudes sub-
sequentes permettent de definir avec precision le type
d'enfant avec IUGR soumis ä examen.
Mots-cles: Croissance (cellulaire), foetus, nouveau-ne, placenta, troubles de croissance.
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